Research On Schizophrenia and Bipolar Disorder

The Stanley Medical Research Institute (SMRI) is a nonprofit organization supporting research on the causes of, and treatments for, schizophrenia and bipolar disorder. Since it began in 1989, SMRI has supported more than $550 million in research in over 30 countries around the world.

*The 2016 Application Cycle has been postponed.

Please visit the Treatment Trials page for more information.*

 

 

Treatment Trial Grants

This program supports the testing of medications to assess their efficacy for treating schizophrenia and bipolar disorder. At any given time, SMRI is supporting 40-50 treatment trials, the majority of which are generic and/or off-label medications. SMRI expects to fund 5-10 additional trials this year.

Brain Research - Tissue Repository

Postmortem samples available from cases with schizophrenia, bipolar disorder, major depression & unaffected controls. Mine >2000 neuropathology datasets, microarray, methylation, SNP & RNA-seq datasets from multiple brain areas.

SMRI Supported Organizations

Stanley Neurovirology Lab at John Hopkins University

The Stanley Program for Epidemiology, Prevention, and Treatment of Schizophrenia

The Treatment Advocacy Center